Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1993HepatologyOpen Access

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

Herbert Tilg
Herbert TilgUniversità Cattolica del Sacro CuoreWVW. VogelUniversity of BernCWChristian J. WiedermannPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tilg et al. (1993) studied this question.

synapsesocial.com/papers/6a93b142a8c8304b7ee1be2chttps://doi.org/10.1002/hep.1840180519
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently1991 · 218 citations
  2. 2Interleukin-1 and interleukin-1 antagonism1991 · 2,271 citations
  3. 3Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes1992 · 98 citations
  4. 4Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction1991 · 453 citations
  5. 5High Prevalence of Viral Infection in Adults with Homozygous and Heterozygous Alpha<sub>1</sub>-Antitrypsin Deficiency and Chronic Liver Disease1992 · 113 citations